• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tobacco, cannabis, and liquorice: Hidden players altering albendazole metabolism in patients with hepatic alveolar echinococcosis.

作者信息

Bresson-Hadni Solange, Montange Damien, Richou Carine, Brumpt Eléonore, Fillion Aurélie, Bartholomot Brigitte, Blagosklonov Oleg, Delabrousse Eric, Grenouillet Frédéric, Vuitton Dominique-Angèle, Millon Laurence

机构信息

Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France; Centre National de Référence Echinococcoses, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France; UMR 6249, Chronoenvironnement, Université de Franche-Comté, 25030 Besançon, France; Services d'Hepato-Gastroenterologie et; de Médecine Tropicale et Humanitaire, Hôpitaux Universitaires de Genève, Suisse.

Laboratoire de Parasitologie-Mycologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France; Laboratoire de Pharmacologie Clinique, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France.

出版信息

J Hepatol. 2021 Feb;74(2):471-473. doi: 10.1016/j.jhep.2020.10.032. Epub 2020 Dec 11.

DOI:10.1016/j.jhep.2020.10.032
PMID:33309328
Abstract
摘要

相似文献

1
Tobacco, cannabis, and liquorice: Hidden players altering albendazole metabolism in patients with hepatic alveolar echinococcosis.烟草、大麻和甘草:影响肝泡型包虫病患者阿苯达唑代谢的潜在因素
J Hepatol. 2021 Feb;74(2):471-473. doi: 10.1016/j.jhep.2020.10.032. Epub 2020 Dec 11.
2
Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up.无法手术的泡型包虫病患者在使用阿苯达唑治疗时的个体化管理:正电子发射断层扫描结合血清学和计算机断层随访的作用。
Clin Microbiol Infect. 2010 Jun;16(6):788-91. doi: 10.1111/j.1469-0691.2009.02924.x. Epub 2009 Nov 13.
3
Inoperable cerebral alveolar echinococcosis controlled with high dosages of albendazole adjusted with monitoring of blood levels.大剂量阿苯达唑治疗并监测血药浓度控制不可手术的脑泡型包虫病
J Travel Med. 2012 May-Jun;19(3):198-201. doi: 10.1111/j.1708-8305.2012.00600.x.
4
[Continuous albendazole therapy in alveolar echinococcosis--evaluation of therapeutic effect with computerized tomography and ultrasonography].[阿苯达唑持续治疗泡型包虫病——应用计算机断层扫描和超声检查评估治疗效果]
Zhonghua Nei Ke Za Zhi. 1992 Dec;31(12):761-3, 780.
5
Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.基于阿苯达唑-壳聚糖微球的治疗对小鼠肺泡型棘球蚴病的疗效
PLoS Negl Trop Dis. 2015 Sep 9;9(9):e0003950. doi: 10.1371/journal.pntd.0003950. eCollection 2015.
6
Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions.阿苯达唑可增强人类肝泡型包虫病病变中多房棘球绦虫(spems)的炎症反应及Em2阳性小颗粒数量。
PLoS Negl Trop Dis. 2017 May 25;11(5):e0005636. doi: 10.1371/journal.pntd.0005636. eCollection 2017 May.
7
Simultaneous occurrence of hepatic alveolar and cystic echinococcosis.肝泡型和囊型棘球蚴病同时发生。
J Helminthol. 2019 Aug 30;94:e80. doi: 10.1017/S0022149X19000385.
8
A case of Budd-Chiari syndrome associated with alveolar echinococcosis.一例与肺泡型棘球蚴病相关的布加综合征病例。
J Pak Med Assoc. 2014 Apr;64(4):465-7.
9
[Computerized tomography of liver in alveolar echinococcosis treated with albendazole].
Zhonghua Nei Ke Za Zhi. 1993 Nov;32(11):733-5.
10
Metabolic mechanism and pharmacological study of albendazole in secondary hepatic alveolar echinococcosis (HAE) model rats.阿苯达唑治疗继发性肝泡型包虫病(HAE)模型大鼠的代谢机制和药效学研究。
Antimicrob Agents Chemother. 2024 May 2;68(5):e0144923. doi: 10.1128/aac.01449-23. Epub 2024 Mar 19.

引用本文的文献

1
Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System.第2部分:18岁及以上人群中涉及大麻产品的药物相互作用:已发表病例报告总结及美国食品药品监督管理局不良事件报告系统分析
Pharmacol Res Perspect. 2025 Feb;13(1):e70047. doi: 10.1002/prp2.70047.
2
Maca against Echinococcosis?-A Reverse Approach from Patient to In Vitro Testing.玛咖对包虫病的作用?——从患者到体外试验的逆向研究方法。
Pathogens. 2021 Oct 15;10(10):1335. doi: 10.3390/pathogens10101335.